title: Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
authors.affiliation: Costello Medical Consulting Ltd., Cambridge, UK.
authors.forename: M
authors.initials: M
authors.lastname: Maruszczak
authors.affiliation: Costello Medical Consulting Ltd., Cambridge, UK.
authors.forename: J
authors.initials: J
authors.lastname: Kusel
authors.affiliation: Novartis Pharmaceuticals UK Limited, Surrey, UK.
authors.forename: N
authors.initials: N
authors.lastname: Adlard